Canada markets closed

Alcoa Corporation (AA)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
12.24+0.69 (+5.97%)
At close: 4:00PM EDT

12.24 0.00 (0.00%)
After hours: 7:48PM EDT

Sign in to post a message.
  • H
    Habib
    Is there something going on with AA that we don’t know? Each time the market is down, AA is down more than twice.
  • T
    Tim
    Top Gainers in the U.S. Stock Markets 🇺🇸

    https://stockreport.tips/Top-Market-Gainers
    YOUR #1 SOURCE FOR THE FASTEST MOVING NASDAQ AND NYSE LISTED STOCKS
    YOUR #1 SOURCE FOR THE FASTEST MOVING NASDAQ AND NYSE LISTED STOCKS
    stockreport.tips
  • A
    Arif
    Very frustrated with my significant investment in this stock. Will it ever see $20 rather $60, it's ATH?
  • s
    stocktargetadvisor
    $AA
    Target Raised by Morgan Stanley Equal Weight USD 12 » USD 14
  • T
    Tammy
    buy ostk
  • T
    Tammy
    buy gn
  • B
    BobZ
    Nice to be positive on AA. I started buying in late January at an average of 13.9, including buying some $15 calls. Modest debt load and higher FCF from the liquid commodity grade product led me to think it was undervalued then. I'm planning to hold it until we see the mid 30's again but am willing to ride it out a couple years.
  • H
    Hong Lai
    Any links can provide aluminum price daily for free? Thanks.
  • S
    STOCK TRADER
    Cramer said he didn’t like Aloca at $5 and it’s triple since then. A 300% increase yet he still doesn’t like it. And he doesn’t admit that he was wrong we lost 300% because of him.
  • J
    John
    I wish I bought more when it was still at $6! But happy I bought what I did when I did! TY AA
  • T
    Thomas
    Someone knows what happend ?? it was up 2.5% pre market ... and now is down 2.5% ??
    tks
  • P
    Phoenix
    Not much gain in premarket.
  • J
    Jodi
    Relief Therapeutics Chairman Sees Covid-19 Drug Earning Millions
    BY CATHERINE BOSLEY
    Aug. 8, 2020, 10:48 AM
    Selvaraju says there’s 60-70% chance of regulatory approval
    Sees annual peak revenue of hundreds of millions of dollars
    Relief Therapeutics’s chairman says the Swiss biotech stands to earn hundreds of millions of dollars if its drug Aviptadil gets a green light from regulators for treating Covid-19, according to an interview with The Market.
    Even with a vaccine, it’ll take some time to get people around the world inoculated, “so our drug would have a potential four to six years of use for patients who are seriously ill, and it could generate hundreds of millions of dollars per year during that time,” Chairman Raghuram Selvaraju was quoted as saying.
    The shares jumped more than 1,600% this week, when...
  • V
    VeriZoo
    It is still a joke.
  • M
    Michael
    The big institutional investors each made big bucks yesterday ..$20 million on their 20 million shares ... not bad. Quite sure they plan to keep it and continue to experience the magic right through $25
  • H
    Heath
    AA reported performance for the second quarter of 2020 in line with the prefatory outcomes previously announced by the organization and demonstrated increased efficiency and sustained organizational stability during the COVID-19 pandemic. Also, check this company as it is flourishing and thriving in the cryptocurrency market. Learn HOW: http://psce.pw/DisruptingaMultiTrillionIndustryHotStocks
    “According to McKinsey, the Global Payments industry is a $1.9 trillion-dollar industry.
    “According to McKinsey, the Global Payments industry is a $1.9 trillion-dollar industry.
    psce.pw
  • V
    VeriZoo
    Zero future.
  • J
    Jackie Dodson
    Tariff.... Whats everyone thoughts about this $AA stock now with imposed tariffs by both USA & Canada
  • T
    Tammy
    buy telsa stock 400's now. Stock split
  • S
    Sean
    Any one got any dd on this company I bought 100 shares but financials looking forward in a year or so look good with there being an aluminum shortage right